THERAPY Colorectal cancer: how to teach an old drug new tricks

被引：0

作者：

Grothey, Axel ^{[1
]}

Ellis, Lee M. ^{[2
,3
]}

机构：

[1] Mayo Clin, Dept Med Oncol, 200 First St South West, Rochester, MN 55905 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77230 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77230 USA

来源：

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2016年 / 13卷 / 07期

关键词：

BRAF;

D O I：

10.1038/nrgastro.2016.87

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Subclassification of colorectal cancers can inform patient prognosis and response to treatment. Beyond these functions, a recent study demonstrates that molecular subtyping can also play an important part in rational drug discovery, uncovering new indications for drugs previously thought ineffective.

引用

页码：384 / +

页数：2

共 50 条

[21] Targeted therapy in advanced colorectal cancer: more data, more questions
Ochenduszko, Sebastian L.
Krzemieniecki, Krzysztof
[J]. ANTI-CANCER DRUGS, 2010, 21 (08) : 737 - 748
[22] BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives
Sanz-Garcia, E.
Argiles, G.
Elez, E.
Tabernero, J.
[J]. ANNALS OF ONCOLOGY, 2017, 28 (11) : 2648 - 2657
[23] Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS
Kishiki, Tomokazu
Ohnishi, Hiroaki
Masaki, Tadahiko
Ohtsuka, Kouki
Ohkura, Yasuo
Furuse, Jyunji
Watanabe, Takashi
Sugiyama, Masanori
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 749 - 757
[24] Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy
Musi, Alice
Bongiovanni, Laura
[J]. CANCERS, 2023, 15 (04)
[25] Managing drug resistance in cancer: lessons from HIV therapy
Bock, Christoph
Lengauer, Thomas
[J]. NATURE REVIEWS CANCER, 2012, 12 (07) : 494 - 501
[26] New RAF kinase inhibitors in cancer therapy
Martin-Liberal, Juan
Larkin, James
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (09) : 1235 - 1245
[27] Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
Lakatos, Gabor
Koehne, Claus-Henning
Bodoky, Gyorgy
[J]. CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1143 - 1157
[28] Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
Gábor Lakatos
Claus-Henning Köhne
György Bodoky
[J]. Cancer and Metastasis Reviews, 2020, 39 : 1143 - 1157
[29] Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal Cancer
Malla, Midhun
Parikh, Aparna R.
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (03) : 583 - 601
[30] Epidermal Growth Factor Receptor-Targeted Therapy of Colorectal Cancer with Panitumumab
Sartore-Bianchi, Andrea
Sporchia, Andrea
Cerea, Giulio
Maugeri, Maria Rosaria
Cipani, Tiziana
Andreotti, Ines
Marrapese, Giovanna
Artale, Salvatore
Siena, Salvatore
[J]. CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 249 - 254

← 1 2 3 4 5 →